Last10K.com

Syneron Medical Ltd. (ELOS) SEC Filing 20-F Annual report for the fiscal year ending Saturday, December 31, 2016

Syneron Medical Ltd.

CIK: 1291361 Ticker: ELOS

View differences made from one year to another to evaluate Syneron Medical Ltd.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Syneron Medical Ltd..

Continue

Assess how Syneron Medical Ltd.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Syneron Medical Ltd.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2017 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 20-F Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Changes In Shareholders' Equity
Consolidated Statements Of Comprehensive Loss
Consolidated Statements Of Operations
Accumulated Other Comprehensive Income (loss)
Accumulated Other Comprehensive Income (loss) (reclassifications Out Of Accumulated Other Comprehensive Income (loss)) (details)
Accumulated Other Comprehensive Income (loss) (tables)
Available-for-sale Marketable Securities
Available-for-sale Marketable Securities (realized Gains And Losses) (narrative) (details)
Available-for-sale Marketable Securities (schedule Of Available-for-sale Securities) (details)
Available-for-sale Marketable Securities (schedule Of Unrealized Loss On Investments) (details)
Available-for-sale Marketable Securities (tables)
Commitments And Contingencies
Commitments And Contingencies (leases) (details)
Commitments And Contingencies (legal Claims) (details)
Commitments And Contingencies (royalties) (details)
Commitments And Contingencies (tables)
Deferred Revenues
Deferred Revenues (reconciliation Of Deferred Revenue) (details)
Deferred Revenues (tables)
Derivative Instruments
Derivative Instruments (fair Value Of Outstanding Derivative Instruments) (details)
Derivative Instruments (schedule Of Cash Flow Hedges Reclassified In Accumulated Other Comprehensive Income) (details)
Derivative Instruments (schedule Of Derivative Instruments Recognized In Other Comprehensive Income) (details)
Derivative Instruments (schedule Of Derivatives Not Designated As Hedging Instruments) (details)
Derivative Instruments (tables)
Disclosure On Related Parties Transaction
Disclosure On Related Parties Transaction (details)
Equity
Equity (option Plans And Stock Appreciation Rights) (narrative) (details)
Equity (schedule Of Assumptions Used To Estimate Fair Value) (details)
Equity (schedule Of Share-based Compensation Expense) (details)
Equity (schedule Of Stock Option Activity By Exercise Price) (details)
Equity (schedule Of Stock Options And Stock Appreciation Rights Award Activity) (details)
Equity (schedule Of Weighted Average Fair Value Of Options Granted) (details)
Equity (summary Of Restricted Stock Activity) (details)
Equity (tables)
Fair Value Measurement
Fair Value Measurement (changes In Level 3 Contingent Consideration Obligations Measured On A Recurring Basis) (details)
Fair Value Measurement (narrative) (details)
Fair Value Measurement (schedule Of Changes In Level 3 Investments Measured On A Recurring Basis) (details)
Fair Value Measurement (schedule Of Financial Assets And Liabilities Measured At Fair Value On A Recurring Basis) (details)
Fair Value Measurement (tables)
Financial Income (expenses), Net
Financial Income (expenses), Net (details)
Financial Income (expenses), Net (tables)
General
General (narrative) (details)
Geographic Information
Geographic Information (schedule Of Revenue And Long-lived Assets By Geographic Regions) (details)
Geographic Information (tables)
Goodwill
Goodwill (details)
Goodwill (narrative) (details)
Goodwill (tables)
Income Taxes
Income Taxes (changes To Unrecognized Tax Benefits) (details)
Income Taxes (corporate Tax Rate) (narrative) (details)
Income Taxes (deferred Taxes) (narrative) (details)
Income Taxes (encouragement Of Industry And Capital Investments) (narrative) (details)
Income Taxes (reconciliation Of Statutory Tax Rate To Effective Tax Rate) (details)
Income Taxes (schedule Of Corporate Income Tax Rate By Jurisdiction) (details)
Income Taxes (schedule Of Deferred Income Taxes) (details)
Income Taxes (schedule Of Loss Before Taxes On Income) (details)
Income Taxes (schedule Of Taxes On Income) (details)
Income Taxes (tables)
Income Taxes (tax Filings Subject To Examination) (details)
Intangible Assets, Net
Intangible Assets, Net (schedule Of Components Of Intangible Assets) (details)
Intangible Assets, Net (schedule Of Estimated Annual Amortization Expense Related To Intangible Assets) (details)
Intangible Assets, Net (tables)
Inventories
Inventories (details)
Inventories (tables)
Investment In Affiliated Company
Investment In Affiliated Company (narrative) (details)
Net Income (loss) Per Share
Net Income (loss) Per Share (computation Of Basic And Diluted Net Loss Per Share) (details)
Net Income (loss) Per Share (schedule Of Anti-dilutive Securities Excluded From Computation Of Diluted Net Loss Per Share) (details)
Net Income (loss) Per Share (tables)
Other Accounts Payable And Accrued Expenses
Other Accounts Payable And Accrued Expenses (details)
Other Accounts Payable And Accrued Expenses (tables)
Other Accounts Receivable And Prepaid Expenses
Other Accounts Receivable And Prepaid Expenses (details)
Other Accounts Receivable And Prepaid Expenses (tables)
Other Expenses (income), Net
Other Expenses (income), Net (details)
Other Expenses (income), Net (narrative) (details)
Other Expenses (income), Net (tables)
Property And Equipment, Net
Property And Equipment, Net (details)
Property And Equipment, Net (tables)
Significant Accounting Policies
Significant Accounting Policies (derivatives And Hedging Activities) (narrative) (details)
Significant Accounting Policies (employee Benefit Plan) (narrative) (details)
Significant Accounting Policies (goodwill And Intangible Assets) (narrative) (details)
Significant Accounting Policies (narrative) (details)
Significant Accounting Policies (policies)
Significant Accounting Policies (schedule Of Change In Allowance For Doubtful Accounts) (details)
Significant Accounting Policies (schedule Of Depreciation Rates) (details)
Significant Accounting Policies (tables)
Significant Accounting Policies (warranty) (details)
Ticker: ELOS
CIK: 1291361
Form Type: 20-F Annual Report
Accession Number: 0001178913-17-000881
Submitted to the SEC: Thu Mar 23 2017 3:40:54 PM EST
Accepted by the SEC: Thu Mar 23 2017
Period: Saturday, December 31, 2016
Industry: Electromedical And Electrotherapeutic Apparatus

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/elos/0001178913-17-000881.htm